NSAIDs in COVID-19, friend or foe?
Abstract
At the beginning of COVID-19 pandemic the use of NSAIDS was avoided. This was because the previous studies suggesting that NSAIDs may be linked to an increased risk of lower respiratory tract infection consequences. Later on studies involved the patients who used NSAIDs for some chronic conditions and showed no additional harm among these patients. Then many studied assessed the benefit of using NSAIDs in COVID-19 patients for management of pain and fever and showed no additional risk among these patients.
Key words:
Citation: Mahrous R, Abdelnasser A, Fouda R, Morsy MAM, Ibrahim MA, Mandour O. NSAIDs in COVID-19, friend or foe? Anaesth. pain intensive care 2022;26(4):427-429; DOI: 10.35975/apic.v26i4.1942
Received: May 29, 2022; Reviewed: June 06, 2022, 2022; Accepted: June 06, 2022